RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kim Kline to Antineoplastic Combined Chemotherapy Protocols

This is a "connection" page, showing publications Kim Kline has written about Antineoplastic Combined Chemotherapy Protocols.
  1. Gopalan A, Yu W, Sanders BG, Kline K. Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol. Cancer Lett. 2013 Jan 28; 328(2):285-96.
    View in: PubMed
    Score: 0.326
  2. Tiwary R, Yu W, Sanders BG, Kline K. a-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73. Breast Cancer Res. 2011 Jan 07; 13(1):R1.
    View in: PubMed
    Score: 0.289
  3. Xiong A, Yu W, Liu Y, Sanders BG, Kline K. Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling. Mol Carcinog. 2016 May; 55(5):420-30.
    View in: PubMed
    Score: 0.096
  4. Riedel SB, Fischer SM, Sanders BG, Kline K. Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice. Anticancer Drugs. 2008 Feb; 19(2):175-81.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support